XM无法为美国居民提供服务。
A
A

Abbott


市场新闻

Abbott bumps up profit forecast on strong medical device sales

UPDATE 2-Abbott bumps up profit forecast on strong medical device sales Adds analyst comments in paragraph 4 and 9, details on other segments in paragraph 8 and shares in paragraph 10 Oct 16 (Reuters) - Abbott Laboratories ABT.N slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong demand for its glucose-monitoring products and other medical devices.
A

Stocks stunned by ASML curveball, pound plunges

MORNING BID AMERICAS-Stocks stunned by ASML curveball, pound plunges A look at the day ahead in U.S. and global markets from Mike Dolan World markets struggled to find a footing on Wednesday after Europe's ASML ASML.AS sideswiped the global chip sector late yesterday with a surprisingly weak orders outlook and investors prayed the flub was a one-off as third-quarter earnings updates stream in.
A
C
G
L
M
N
S
J
U
U
U
C
E
P

What to Watch in the Day Ahead - Wednesday, October 16

What to Watch in the Day Ahead - Wednesday, October 16 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Morgan Stanley will report its third-quarter results.
A
C
C

What to Watch in the Week Ahead and on Monday, October 14

What to Watch in the Week Ahead and on Monday, October 14 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of Minneapolis President Neel Kashkari will participate in a panel discussion at the Central Bank of Argentina's Money and Banking Conference on "Fiscal Defic
A
C
G
N
W
F
U
C
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Oct 11 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 15-Oct-2024 AMC JBHT.O J B Hunt Transport Services Inc Q3 2024 J B Hunt Transport Services Inc Earnings Release 15-Oct-2024 AMC UAL.O United Airlines Holdings Inc Q3 2024 United Airlines Holdings Inc Earnings Release 15-Oct-2024 AMC OMC Omnicom Group
A
C
C
G
H
N
S
W
F
J
U
C
E
M
P
S

Abbott Advances Pulsed Field Ablation Clinical Studies

BRIEF-Abbott Advances Pulsed Field Ablation Clinical Studies Oct 10 (Reuters) - Abbott Laboratories ABT.N : ABBOTT ADVANCES PULSED FIELD ABLATION CLINICAL STUDIES AND LAUNCHES NEW TECHNOLOGY TO SUPPORT ADVANCED CARDIAC MAPPING ABBOTT: GLOBAL FOCALFLEX TRIAL NOW UNDERWAY FOR ABBOTT'S TACTIFLEX™ DUO ABLATION CATHETER, SENSOR ENABLED™ ABBOTT: ADVISOR™ HD GRID X MAPPING CATHETER, SENSOR ENABLED™, RECEIVES U.S.
A

U.S. Abbott, Gilead, Roku

U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Abbott, Gilead and Roku, on Thursday. HIGHLIGHTS * Abbott ABT.N : JP Morgan raises target price to $135 from $125 * AIG AIG.N : JP Morgan raises to overweight from neutral * Gilead GILD.O : Raymond James raises target price to $95 from $94 * Lendingclub Corp LC.N : KBW raises to outperform from market perform * Roku Inc R
A
C
G
P
C
I
S
A
G
H
P
U

Medical device makers need to 'beat or raise' for stocks to move higher, RBC says

BUZZ-Medical device makers need to 'beat or raise' for stocks to move higher, RBC says ** Analysts at RBC Capital Markets expect procedures to remain strong for remainder of the year, but see downturn in elective procedures in Q3 due to vacation schedules ** Investor sentiment will continue to play key role in how stocks respond given the high-bar,
A

WHO approves first mpox diagnostic test for emergency use

UPDATE 4-WHO approves first mpox diagnostic test for emergency use Updates Oct. 3 story to add company statement in paragraph 4 Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' ABT.N mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.
A
R
L

Jury urged to hold formula makers responsible for premature baby's illness

UPDATE 1-Jury urged to hold formula makers responsible for premature baby's illness Adds material from Abbott, Mead Johnson opening statements By Brendan Pierson Oct 2 (Reuters) - A lawyer for a Missouri mother on Wednesday urged jurors to hold Abbott ABT.N , Reckitt's RKT.L Mead Johnson unit and St. Louis Children's Hospital responsible for a severe intestinal illness that she says her prematurely born son developed after the hospital fed him the companies' formulas.
A

Jury urged to hold formula makers responsible for premature baby's illness

Jury urged to hold formula makers responsible for premature baby's illness By Brendan Pierson Oct 2 (Reuters) - A lawyer for a Missouri mother on Wednesday urged jurors to hold Abbott ABT.N , Reckitt's RKT.L Mead Johnson unit and St. Louis Children's Hospital responsible for a severe intestinal illness that she says her prematurely born son developed after the hospital fed him the companies' formulas.
A

U.S. STOCKS Dine Brands, Pinterest, Nike

BUZZ-U.S. STOCKS ON THE MOVE-Dine Brands, Pinterest, Nike Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes took a beating on Tuesday as reports of escalating tensions in the Middle East made investors sell riskier assets, with the benchmark S&P 500 hitting its lowest in over a week.
A
A
C
L
N
P
S
L
U
U
L
A
C
J
M

Uptake of Dexcom's OTC glucose monitor Stelo outpaces Abbott's Lingo, Citi says

BUZZ-Uptake of Dexcom's OTC glucose monitor Stelo outpaces Abbott's Lingo, Citi says ** Brokerage Citi says early uptake of Dexcom's DXCM.O over-the-counter continuous glucose monitor Stelo is ahead of Abbott's ABT.N Lingo ** Stelo is gaining traction benefitting from an earlier launch compared to Lingo - Citi ** Adds app data points to a recovery for Dexcom, after the glucose monitor maker slashed its annual revenue forecast ** Brokerage says downloads of apps for Dexcom's continuous glucose mo
A

UK's Reckitt falls after court trial over premature baby formula begins

BUZZ-UK's Reckitt falls after court trial over premature baby formula begins ** Shares of Enfamil formula maker Reckitt RKT.L down 1.15% at 4,524p ** Co's unit Mead Johnson, along with US-based Abbott ABT.N , is facing a trial over its premature baby formula causing a severe intestinal illness ** Plaintiffs argue companies failed to warn about the
A

UK Stocks-Factors to watch on Oct 1

UPDATE 1-UK Stocks-Factors to watch on Oct 1 Adds new items, updates futures Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0 .4%. * HALEON: Pfizer PFE.N offloaded shares worth roughly $3.26 billion in Haleon HLN.L at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said.
A
G
P
R

UK Stocks-Factors to watch on Oct 1

UK Stocks-Factors to watch on Oct 1 Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0.34% * HALEON: Pfizer's PFE.N stake sale in British consumer healthcare company Haleon HLN.L has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
A
P

Abbott, Reckitt face trial over premature baby formula amid alarm from doctors

CORRECTED-Abbott, Reckitt face trial over premature baby formula amid alarm from doctors Corrects title of Jonathan Davis in paragraph 9, to Chief of Newborn Medicine at Tufts Medical Center Doctors fear losing access to essential formulas for premature babies Plaintiffs argue companies failed to warn about NEC risk from cow's milk-based formula By Brendan Pierson Sept 30 (Reuters) - A Missouri mother and her lawyers this week will aim to convince a jury that Abbott ABT.N , Reckitt's RKT.L Mead
A

Indian shares set to open higher on US rate-cut euphoria

INDIA STOCKS-Indian shares set to open higher on US rate-cut euphoria BENGALURU, Sept 20 (Reuters) - Indian shares are set to open higher on Friday, as an outsized interest rate reduction by the U.S. Federal Reserve and the anticipation of a soft landing for the world's largest economy boosted risk appetite across global markets. The GIFT Nifty GIFc1 was at 25,523 points, as of 07:55 a.m.
A
U

U.S. STOCKS Children's Place, US energy sector, retailers

BUZZ-U.S. STOCKS ON THE MOVE-Children's Place, US energy sector, retailers Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes soared on Thursday with the S&P 500 and the Dow hitting intraday record highs after the Federal Reserve kicked off its monetary easing cycle with half-a-percentage point reduction and forecast more interest rate cuts were on the hor
A
A
C
C
I
J
L
M
N
T
A
U
F
R
U
U
S
D

Abbott Declares Qtrly Common Dividend Of 55 Cents/Shr

BRIEF-Abbott Declares Qtrly Common Dividend Of 55 Cents/Shr Sept 19 (Reuters) - Abbott Laboratories ABT.N : ABBOTT - DECLARED A QUARTERLY COMMON DIVIDEND OF 55 CENTS PER SHARE ABBOTT DECLARES 403RD CONSECUTIVE QUARTERLY DIVIDEND Source text for Eikon: ID:nPnbB2dYca Further company coverage: ABT.N
A



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明